Sunmark Junior Rapid Melts

Description

Sunmark Junior Rapid Melts are formulated as a pain reliever and fever reducer, containing acetaminophen as the active ingredient. This product is specifically designed for children aged 6 to 11 years. Each tablet is presented in a bubblegum flavor, enhancing palatability for the intended age group. The packaging includes a total of 24 tablets, providing a convenient dosage form for administration.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with the common cold, flu, and headache. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The appropriate dosage of this product should be determined based on the patient's weight or age, as outlined in the dosage chart below. It is imperative that healthcare professionals adhere to the recommended dosing guidelines and avoid exceeding the maximum dosage to prevent potential overdose.

For patients weighing under 48 lbs or under 6 years of age, it is advised to consult a physician for appropriate dosing recommendations. For patients weighing between 48-59 lbs or aged 6-8 years, the recommended dosage is 2 tablets. For those weighing between 60-71 lbs or aged 9-10 years, the dosage is 2 ½ tablets. Patients weighing between 72-95 lbs or aged 11 years should receive 3 tablets.

The tablets should be dissolved in the mouth or chewed thoroughly before swallowing. If symptoms persist, the dose may be repeated every 4 hours as needed; however, it is crucial not to exceed 5 doses within a 24-hour period. Additionally, treatment should not extend beyond 5 days unless directed by a healthcare professional.

Contraindications

Use of this product is contraindicated in the following situations:

• Concurrent use with any other product containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose.

• In children with a known allergy to acetaminophen or any inactive ingredients in this formulation.

Caution is advised, and a healthcare professional should be consulted prior to use if the child has liver disease or is taking the anticoagulant warfarin.

Exceeding the recommended dosage is contraindicated, as it may lead to liver damage. The maximum dosage should not exceed five doses within a 24-hour period, and administration should not extend beyond five days unless directed by a physician.

Patients should discontinue use and seek medical advice if pain worsens or persists beyond five days, if fever worsens or lasts more than three days, if new symptoms arise, or if there is any redness or swelling. In the event of an overdose, immediate medical assistance or contact with a poison control center is essential, even in the absence of symptoms.

Warnings and Precautions

Severe liver damage may occur in children taking this product, which contains acetaminophen, if they exceed five doses within a 24-hour period or if they use it concurrently with other medications containing acetaminophen.

It is imperative to avoid the use of this product alongside any other acetaminophen-containing medications, whether prescription or nonprescription. Healthcare professionals should advise caregivers to consult a doctor or pharmacist if there is uncertainty regarding the use of other drugs. Additionally, this product should not be administered to children with a known allergy to acetaminophen or any of its inactive ingredients.

Before using this product, it is essential to consult a healthcare provider if the child has a history of liver disease. Furthermore, caregivers should seek guidance from a doctor or pharmacist if the child is currently taking warfarin, a blood-thinning medication, due to potential interactions.

In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted without delay. Prompt medical attention is crucial, even if no signs or symptoms are initially apparent.

Caregivers should discontinue use and consult a healthcare professional if the child experiences worsening pain lasting more than five days, a fever that persists beyond three days, the emergence of new symptoms, or any signs of redness or swelling. These may indicate a serious underlying condition. It is also critical to keep this product out of reach of children to prevent accidental ingestion.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly concerning liver health. The product contains acetaminophen, and severe liver damage may occur if the maximum daily amount of more than 5 doses is exceeded within a 24-hour period or if it is taken concurrently with other medications containing acetaminophen.

It is crucial to avoid using this product in conjunction with any other acetaminophen-containing products, whether prescription or nonprescription. Patients should consult a doctor or pharmacist before using this product alongside other medications if there is any uncertainty. Additionally, this product should not be used by patients who have a known allergy to acetaminophen or any of the inactive ingredients present in the formulation.

Before using this product, patients with liver disease should seek medical advice. Furthermore, those taking the anticoagulant warfarin should also consult a healthcare professional prior to use.

Patients are advised to adhere strictly to the recommended dosage to prevent overdose, which may lead to liver damage. In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted, as prompt medical attention is essential even if no symptoms are initially apparent.

Patients should discontinue use and consult a doctor if pain worsens or persists for more than 5 days, if fever intensifies or lasts longer than 3 days, if new symptoms arise, or if there is any redness or swelling, as these may indicate a serious condition.

Drug Interactions

It is advisable for patients to consult a healthcare professional, such as a doctor or pharmacist, before using this medication in conjunction with other drugs, particularly if there is uncertainty regarding potential interactions.

Co-administration with any product containing acetaminophen, whether prescription or nonprescription, is contraindicated. This is to prevent the risk of acetaminophen overdose, which can lead to serious liver damage.

Additionally, caution is warranted if the patient’s child is concurrently taking warfarin, a blood-thinning medication. It is recommended to seek guidance from a healthcare provider before initiating use to ensure safe and effective management of both medications.

Packaging & NDC

Below are the non-prescription pack sizes of Sunmark Junior Rapid Melts (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not be given this medication without consulting a doctor. For children aged 6 to 11 years, dosing is weight-based: those weighing 48-59 lbs (ages 6-8 years) may receive 2 tablets, those weighing 60-71 lbs (ages 9-10 years) may receive 2 1/2 tablets, and those weighing 72-95 lbs (age 11 years) may receive 3 tablets.

The maximum daily dose should not exceed 5 doses within a 24-hour period, and treatment should not extend beyond 5 days unless directed by a healthcare professional. Caution is advised due to the risk of severe liver damage if the child exceeds the maximum dose or is taking other medications containing acetaminophen.

Healthcare providers should be consulted prior to use if the child has liver disease or is taking the anticoagulant warfarin. Parents and caregivers are advised to discontinue use and seek medical advice if the child's pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, if new symptoms develop, or if there is any redness or swelling.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that no specific information regarding the use of this product during pregnancy is provided in the prescribing information. There are no statements indicating whether the product is contraindicated in pregnancy or any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions regarding the use of this product during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions mentioned related to lactation. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns based on the available data.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. It is essential to note that severe liver damage may occur if the maximum daily amount of 5 doses is exceeded within a 24-hour period or if the patient is concurrently taking other medications that contain acetaminophen.

Before administering this product, it is advised to consult a healthcare professional if the patient has a history of liver disease. In cases of overdose, which may result from taking more than the recommended dose, immediate medical assistance should be sought, or a poison control center should be contacted. Prompt medical attention is critical, even if the patient does not exhibit any signs or symptoms of liver damage.

Overdosage

Taking more than the recommended dose of this medication may lead to significant liver damage. It is imperative that healthcare professionals remain vigilant regarding the potential for overdose and its serious consequences.

In the event of an overdose, immediate medical assistance should be sought. Healthcare providers are advised to contact a poison control center without delay. Quick medical attention is crucial, even in the absence of noticeable signs or symptoms, as early intervention can be vital in mitigating the effects of an overdose.

Monitoring and management of the patient should be initiated promptly, with a focus on assessing liver function and implementing appropriate therapeutic measures as guided by clinical protocols.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription, and to consult a doctor or pharmacist if there is uncertainty regarding the use of other drugs.

Patients should be cautioned against using this product if their child has a known allergy to acetaminophen or any of the inactive ingredients. Additionally, healthcare providers should recommend that patients seek medical advice before use if their child has liver disease or is taking the blood-thinning medication warfarin.

When using this product, patients must be instructed to adhere strictly to the recommended dosage, as exceeding this may lead to serious consequences, including liver damage. In the event of an overdose, immediate medical assistance should be sought, or a poison control center contacted, even if no symptoms are apparent, as prompt medical attention is crucial.

Patients should be informed to discontinue use and consult a doctor if any of the following occur: pain worsens or persists beyond 5 days, fever worsens or lasts more than 3 days, new symptoms arise, or if there is any redness or swelling, as these may indicate a serious condition.

Healthcare providers should guide patients on the correct dosing, emphasizing the importance of using weight for dosing when possible, or age if weight is not available. The product should be administered by dissolving in the mouth or chewing before swallowing, with the possibility of repeating the dose every 4 hours as needed, but not exceeding 5 doses in a 24-hour period or using it for more than 5 days unless directed by a physician.

Patients should also be reminded to store the product at a controlled room temperature between 20-25°C (68-77°F) and to check the end flap for the expiration date and lot number.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which can be found on the packaging. It is essential to store the product at a controlled room temperature, maintaining a range between 20-25°C (68-77°F). For proper inventory management, the expiration date and lot number are located on the end flap of the packaging. Special handling requirements should be adhered to in order to ensure the integrity and efficacy of the product throughout its shelf life.

Additional Clinical Information

The medication is administered orally. Clinicians should counsel patients to keep the medication out of reach of children. It is advised that patients consult a doctor before use if the child has liver disease or is taking the blood-thinning medication warfarin. Patients should discontinue use and seek medical advice if pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, if new symptoms arise, or if there is any redness or swelling.

Drug Information (PDF)

This file contains official product information for Sunmark Junior Rapid Melts, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)